GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pure Extracts Technologies Corp (STU:PUX) » Definitions » EV-to-EBIT

Pure Extracts Technologies (STU:PUX) EV-to-EBIT : -0.73 (As of Jun. 07, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Pure Extracts Technologies EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Pure Extracts Technologies's Enterprise Value is €1.94 Mil. Pure Extracts Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was €-2.65 Mil. Therefore, Pure Extracts Technologies's EV-to-EBIT for today is -0.73.

The historical rank and industry rank for Pure Extracts Technologies's EV-to-EBIT or its related term are showing as below:

STU:PUX's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 16.43
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Pure Extracts Technologies's Enterprise Value for the quarter that ended in Mar. 2023 was €1.86 Mil. Pure Extracts Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was €-2.65 Mil. Pure Extracts Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 was -142.56%.


Pure Extracts Technologies EV-to-EBIT Historical Data

The historical data trend for Pure Extracts Technologies's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pure Extracts Technologies EV-to-EBIT Chart

Pure Extracts Technologies Annual Data
Trend Jun21 Jun22
EV-to-EBIT
-1.15 -0.99

Pure Extracts Technologies Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.49 -0.99 -0.92 -0.51 -0.88

Competitive Comparison of Pure Extracts Technologies's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Pure Extracts Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pure Extracts Technologies's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pure Extracts Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Pure Extracts Technologies's EV-to-EBIT falls into.



Pure Extracts Technologies EV-to-EBIT Calculation

Pure Extracts Technologies's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1.938/-2.645
=-0.73

Pure Extracts Technologies's current Enterprise Value is €1.94 Mil.
Pure Extracts Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pure Extracts Technologies  (STU:PUX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Pure Extracts Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2023 ) =EBIT / Enterprise Value (Q: Mar. 2023 )
=-2.645/1.8553913
=-142.56 %

Pure Extracts Technologies's Enterprise Value for the quarter that ended in Mar. 2023 was €1.86 Mil.
Pure Extracts Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pure Extracts Technologies EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Pure Extracts Technologies's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Pure Extracts Technologies (STU:PUX) Business Description

Traded in Other Exchanges
N/A
Address
7341 Industrial Way, Unit 6, Pemberton, BC, CAN, V0N 2K0
Pure Extracts Technologies Corp is a plant-based extraction company. The company specializes in the processing of cannabis, hemp and functional mushrooms to produce oils and various derivative products. Also, the company is involved in white labelling activities as well as selling branded oil-based products. It has three operating segments, the extraction and processing of cannabis and hemp, the development and commercialization of functional wellness products including psychedelic medicinal products, and its head office.

Pure Extracts Technologies (STU:PUX) Headlines

No Headlines